Product
Danaparoid Sodium
1 clinical trial
1 indication
Indication
Heparin-induced ThrombocytopeniaClinical trial
Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HITStatus: Terminated, Estimated PCD: 2022-06-10